Rasagiline Tablet
Product Images NDC 80005-142

Each tablet of this product contains 0.5 mg of rasagiline, which is equivalent to 0.78 mg of rasagiline mesylate. Dosage information can be found in the accompanying prescribing information. The packaging is child-resistant and should be stored at temperatures between 20°C to 25°C (68°F to 77°F), with excursions permitted up to 15°C to 30°C (59°F to 86°F). This product is manufactured and distributed by Carnegie Pharmaceuticals, LLC in Delran, NJ, USA. It is made in the USA and is available by prescription only. The product has a specific lot number and expiration date, as well as a unique serial number. Additional information such as batch details and data matrices are included on the label for traceability and quality control purposes.*

Each tablet of Rasagiline contains 0.5 mg of the active ingredient, equivalent to 0.78 mg of rasagiline mesylate. Dosage information should be consulted in the accompanying prescribing information. The package is child-resistant and should be stored at temperatures between 20-25°C (68-77°F), with excursions permitted to 15-30°C (50-86°F). This product is manufactured and distributed by Carnegie Pharmaceuticals, LLC in Delran, NJ, USA. It is made in the USA and is only available by prescription. The packaging contains relevant details such as the NDC number, lot number, expiration date, and a unique serial number.*

This text provides information on a tablet containing 0.5 g of rasagiline, which is equivalent to 0.78 mg of rasagiline mesylate. The dosage details are to be referred to accompanying prescribing information. It instructs to store the tablets between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets should be dispensed in a tight container with child-resistant closure. The manufacturer is Carnegie Pharmaceuticals LLC in Delran, USA. The text also mentions that the container is not intended for household use. The tablets are labeled as Rasagiline Tablets, with a pack size of 500 tablets. The information is intended for prescription use only.*

Each tablet contains 1 mg rasagiline (equivalent to 1.56 mg rasagiline mesylate). Dosage information can be found in the accompanying prescribing information. The package is child-resistant and should be stored at temperatures between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). This medication is manufactured and distributed by Carnegie Pharmaceuticals, LLC in Delran, NJ, 08075, USA. It is made in the USA. The label includes the National Drug Code (NDC) as 80005-142-08. Rasagiline Tablets are prescription only. This product does not have printed barcode or data matrix.*

This text provides information about a medication called rasagiline. Each tablet contains 1 mg of rasagiline, which is equivalent to 1.56 mg of rasagiline mesylate. The dosage instructions should be followed as per the accompanying prescribing information. The package is child-resistant and should be stored between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The medication is manufactured and distributed in the USA by Carnegie Pharmaceuticals LLC. The medication is available in tablet form and is for prescription use only.*

This text provides information about rasagiline tablets, each containing 1 mg of rasagiline (equivalent to 1.56 mg of rasagiline mesylate). The dosage instructions are to be found in the accompanying prescribing information. It instructs to store the tablets at a temperature between 20 to 25°C (68 to 77°F) with excursions permitted between 15 to 30°C (59 to 86°F). The tablets should be dispensed in a tight container with a child-resistant closure. The product is not intended for household use and is manufactured and distributed by Carnegie Pharmaceuticals LLC. The packaging contains 500 tablets.*